Neurosense Therapeutics Ltd. (NRSN)
0.415
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 10:55
Neurosense Therapeutics Market Cap : 9.640M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 9.712M |
| September 04, 2026 | 11.87M |
| September 03, 2026 | 9.329M |
| September 02, 2026 | 9.542M |
| September 01, 2026 | 9.758M |
| August 31, 2026 | 9.912M |
| August 28, 2026 | 9.765M |
| August 27, 2026 | 8.694M |
| August 26, 2026 | 13.32M |
| August 25, 2026 | 12.45M |
| August 24, 2026 | 12.21M |
| August 21, 2026 | 12.25M |
| August 20, 2026 | 11.41M |
| August 19, 2026 | 12.96M |
| August 18, 2026 | 12.44M |
| August 17, 2026 | 14.06M |
| August 14, 2026 | 14.75M |
| August 13, 2026 | 14.43M |
| August 12, 2026 | 15.26M |
| August 11, 2026 | 15.45M |
| August 10, 2026 | 15.76M |
| August 07, 2026 | 16.28M |
| August 06, 2026 | 16.38M |
| August 05, 2026 | 17.64M |
| August 04, 2026 | 16.93M |
| Date | Value |
|---|---|
| August 03, 2026 | 15.20M |
| July 31, 2026 | 15.15M |
| July 30, 2026 | 15.50M |
| July 29, 2026 | 15.63M |
| July 28, 2026 | 18.18M |
| July 27, 2026 | 19.11M |
| July 24, 2026 | 19.60M |
| July 23, 2026 | 21.32M |
| July 22, 2026 | 21.16M |
| July 21, 2026 | 22.79M |
| July 20, 2026 | 22.45M |
| July 17, 2026 | 22.27M |
| July 16, 2026 | 22.86M |
| July 15, 2026 | 23.41M |
| July 14, 2026 | 23.77M |
| July 13, 2026 | 23.77M |
| July 10, 2026 | 23.72M |
| July 09, 2026 | 23.44M |
| July 08, 2026 | 23.07M |
| July 07, 2026 | 23.05M |
| July 06, 2026 | 22.66M |
| July 02, 2026 | 23.05M |
| July 01, 2026 | 16.79M |
| June 30, 2026 | 16.72M |
| June 29, 2026 | 16.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 11.05M |
| XTL Biopharmaceuticals Ltd. | 5.985M |
| Kamada Ltd. | 475.98M |
| Can-Fite BioPharma Ltd. | 2.909M |
| Galmed Pharmaceuticals Ltd. | 4.386M |
Market Cap Related Metrics
| Price | 0.415 |